Search Results - "Wiesner, RH"

MELD accurately predicts mortality in patients with alcoholic hepatitis by DUNN, Winston, JAMIL, Laith H, BROWN, Larry S, WIESNER, Russell H, KIM, W. Ray, NARAYANAN MENON, K. V, MALINCHOC, Michael, KAMATH, Patrick S, SHAH, Vijay

“…Assessing severity of disease in patients with alcoholic hepatitis (AH) is useful for predicting mortality, guiding treatment decisions, and stratifying…”
Get full text

A model to predict survival in patients with end-stage liver disease by Kamath, Patrick S., Wiesner, Russell H., Malinchoc, Michael, Kremers, Walter, Therneau, Terry M., Kosberg, Catherine L., D'Amico, Gennaro, Dickson, E.Rolland, Kim, W.Ray

“…A recent mandate emphasizes severity of liver disease to determine priorities in allocating organs for liver transplantation and necessitates a disease…”
Get full text

Natural history of hepatopulmonary syndrome : Impact of liver transplantation by SWANSON, Karen L, WIESNER, Russell H, KROWKA, Michael J

“…Few data exist concerning survival after the diagnosis of hepatopulmonary syndrome (HPS). Although orthotopic liver transplantation (OLT) frequently results in…”
Get full text

Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis by Jorgensen, R A, Lindor, K D, Sartin, J S, LaRusso, N F, Wiesner, R H

“…We reviewed the initial lipid and fat-soluble vitamin levels in 56 patients with primary sclerosing cholangitis (PSC) enrolled in a randomized,…”
Get more information

Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy by Wiesner, Russell H., Freeman, Richard B., Mulligan, David C.

“…Recent reports suggest that selected patients undergoing liver transplantation for stage 1–2 hepatocellular cancer (HCC) have an excellent long-term survival…”
Get full text

The new liver allocation system: Moving toward evidence-based transplantation policy by Freeman, Richard B., Wiesner, Russell H., Harper, Ann, McDiarmid, Sue V., Lake, Jack, Edwards, Erick, Merion, Robert, Wolfe, Robert, Turcotte, Jeremiah, Teperman, Lewis

“…In 1999, the Institute of Medicine suggested that instituting a continuous disease severity score that de-emphasizes waiting time could improve the allocation…”
Get full text

Results of the first year of the new liver allocation plan by Freeman, Richard B., Wiesner, Russell H., Edwards, Erick, Harper, Ann, Merion, Robert, Wolfe, Robert

“…Liver allocation policy in the U.S. was recently changed to a continuous disease severity scale with minimal weight given to time waiting in an effort to…”
Get full text

MELD and PELD: Application of survival models to liver allocation by Wiesner, Russell H., McDiarmid, Sue V., Kamath, Patrick S., Edwards, Eric B., Malinchoc, Michael, Kremers, Walter K., Krom, Ruud A.F., Kim, W.Ray

Get full text

Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis C by Wiesner, Russell H., Sorrell, Michael, Villamil, Federico, International Liver Transplantation Society Expert Panel

Get full text

Improving liver allocation: MELD and PELD by Freeman, Richard B., Wiesner, Russell H., Roberts, John P., McDiarmid, Suzanne, Dykstra, Dawn M., Merion, Robert M.

“…On February 27, 2002, the liver allocation system changed from a status‐based algorithm to one using a continuous MELD/PELD severity score to prioritize…”
Get full text

Risk Factors for and Clinical Course of Non‐Anastomotic Biliary Strictures After Liver Transplantation by Guichelaar, Maureen M. J., Benson, Joanne T., Malinchoc, Michael, Krom, Ruud A. F., Wiesner, Russell H., Charlton, Michael R.

“…Non‐anastomotic biliary stricture (NAS) formation is a major complication of liver transplantation. We prospectively determined the time to development of…”
Get full text

Differential Effects of Donor Age in Liver Transplant Recipients Infected With Hepatitis B, Hepatitis C and Without Viral Hepatitis by Lake, John R., Shorr, Jolene S., Steffen, Bettina J., Chu, Alice H., Gordon, Robert D., Wiesner, Russell H.

“…The variable impact of specific risk factors on survival outcomes based on pre‐transplantation diagnosis was analyzed in adult liver transplant recipients…”
Get full text

Pulmonary Hemodynamics and Perioperative Cardiopulmonary-Related Mortality in Patients With Portopulmonary Hypertension Undergoing Liver Transplantation by Krowka, Michael J., Plevak, David J., Findlay, James Y., Rosen, Charles B., Wiesner, Russell H., Krom, Ruud A.F.

“…In the setting of moderate to severe pulmonary artery hypertension, orthotopic liver transplantation (OLT) may be complicated by pulmonary hemodynamic…”
Get full text

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients by Kremers, Walter K., van IJperen, Marrije, Kim, W. Ray, Freeman, Richard B., Harper, Ann M., Kamath, Patrick S., Wiesner, Russell H.

“…The Model for End‐Stage Liver Disease (MELD) score is predictive of survival and is used to prioritize patients with chronic liver disease patients for…”
Get full text

Post‐Transplant Lymphoproliferative Disorders Following Liver Transplantation: Incidence, Risk Factors and Survival by Kremers, W. K., Devarbhavi, H. C., Wiesner, R. H., Krom, R. A. F., Macon, W. R., Habermann, T. M.

“…This study investigates retrospectively the incidence, risk factors and mortality of post‐transplant lymphoproliferative disorders (PTLD) in adult orthotopic…”
Get full text

Liver transplantation for hepatocellular carcinoma: The MELD impact by Sharma, Pratima, Balan, Vijayan, Hernandez, Jose L., Harper, Ann M., Edwards, Erick B., Rodriguez‐Luna, Hector, Byrne, Thomas, Vargas, Hugo E., Mulligan, David, Rakela, Jorge, Wiesner, Russell H.

“…The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end‐stage liver disease (MELD) gives candidates with stage T1 or…”
Get full text

Evidence‐based evolution of the MELD/PELD liver allocation policy by Wiesner, Russell H.

Get full text

MELD / PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease by Wiesner, Russell H.

“…Key Points 1 Historical perspective of donor allocation to patients with fulminant hepatic failure (FHF). 2 Predicting prognosis in patients with FHF using the…”
Get full text

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders by PAYA, C. V, FUNG, J. J, BROMBERG, J. S, NALESNIK, M. A, KIEFF, E, GREEN, M, GORES, G, HABERMANN, T. M, WIESNER, R. H, SWINNEN, L. J, WOODLE, E. S

“…Epstein-Barr virus-induced posttransplant lymphoproliferative disease (EBV-PTLD) continues to be a major complication after solid organ transplantation in…”
Get full text

Mycophenolate mofetil combination therapy improves long‐term outcomes after liver transplantation in patients with and without hepatitis C by Wiesner, Russell H., Shorr, Jolene S., Steffen, Bettina J., Chu, Alice H., Gordon, Robert D., Lake, John R.

“…To evaluate the impact of mycophenolate mofetil (MMF) on long‐term outcomes of tacrolimus and corticosteroids, we analyzed data reported to the Scientific…”
Get full text